Recurrent Intraocular Pressure Elevation during Hemodialysis in a Patient with Neovascular Glaucoma.
10.3341/kjo.2006.20.2.109
- Author:
Won Kyung SONG
1
;
Seung Joo HA
;
Ho Yeup YEOM
;
Gong Jae SEOUNG
;
Young Jae HONG
Author Information
1. The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine Hospital, Seoul, Korea. sjha@yumc.yonsei.ac.kr
- Publication Type:Case Reports
- Keywords:
Ahmed valve;
Hemodialysis;
Intraocular pressure (IOP);
Neovascular glaucoma (NVG)
- MeSH:
Renal Dialysis/*adverse effects;
Recurrence;
Male;
Kidney Failure, Chronic/complications/*therapy;
Intraocular Pressure/*physiology;
Humans;
Glaucoma, Neovascular/complications/*physiopathology/surgery;
Glaucoma Drainage Implants;
Follow-Up Studies;
Filtering Surgery/instrumentation;
Adult
- From:Korean Journal of Ophthalmology
2006;20(2):109-112
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To report a patient with symptomatic intraocular pressure (IOP) elevation in an eye with neovascular glaucoma (NVG) during hemodialysis. METHODS: Case report. RESULTS: Recurrent episodes of severe ocular pain and elevated IOP in the NVG eye were noted during hemodialysis in a 29-year-old man. The patient was recently diagnosed at our ophthalmology clinic with NVG due to central retinal vein occlusion. IOP was temporarily controlled after the Ahmed valve implantation. However, after the fibrous membrane developed and occluded the tip of the Ahmed valve, IOP elevation during hemodialysis recurred. Further treatments with intravenous mannitol, oral carbonic anhydrase inhibitor, topical antiglaumatic agents and subconjunctival 5-fluorouracil (5-FU) injections all failed to control relapsing pain and IOP elevation. Eventually, evisceration and hydroxyappatite implantation were performed. CONCLUSIONS: Physicians must be alert to the possibility of IOP elevation in glaucomatous eyes during hemodialysis.
